AB Science S.A.

ABSCF·OTC Markets OTCPK·Healthcare

Compare

1.12000.0000 (0.00%)today

At close: Oct 16, 4:00 PM EDT · May be delayed up to 15 min · USD

Key statistics

Previous close1.1200

Open2.7000

Day range1.12002.7000

52-week range1.12002.7000

Off day high−58.52%

Off 52-week high−58.52%

Volume1.45K

Avg. volume (3M)0.00

Market cap108.11M

EPS (TTM)-0.0300

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)—

Shares outstanding96.53M

Short interest—

Earnings dateMay 12, 2025

Analyst target—

Profit margin0.00%

Related companies

Compare ›

What visitors to ABSCF's page also look at.

Company	Mkt cap	Price	Today
SPEAKEASY CANNABIS CLUB LTDSPBBF	1.32K	0.0000	0.00%
WOWI INCWOWU	3.38K	0.0001	0.00%
GENSIGHT BIOLOGICS SAGSGTF	19.62M	0.0800	0.00%
ALTERNATE HEALTH CORPAHGIF	7.79K	0.0001	0.00%
OXE MARINE ABCMMCF	18.86M	0.0200	0.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All ABSCF news ›

The Manila Times·5d ago

AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.

AB SCIENCE WILL HOLD A WEB CONFERENCE ON WEDNESDAY, OCTOBER 14, FROM 6:00 P.M. TO 7:30 P.M. Paris, October 12, 2026, 6:00 p.m. AB Science SA (Euronext - FR0010557264 - AB) will hold a web conference on Wednesday, October 14, 2026, from…

TipRanks Financial·5d agoNegative

AB Science Schedules Investor Web Conference to Detail Governance and Growth Outlook

An announcement from AB Science SA ( (FR:AB) ) is now available. More about AB Science SA YTD Price Performance: -65.89% Average Trading Volume: 448,338 Current Market Cap: €50.58M For detailed information about AB stock, go to TipRanks’…

From articles in the 4Search news index.

In the news

2mentions in 30 days

2with it in the headline

Negativesentiment

Most coverage from

manilatimes.net1
tipranks.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

About

Profile ›

AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company's lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer's disease, and indolent systemic mastocytos…

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Chief executiveStéphane C. Ledermann

Employees26

HeadquartersParis, France

Websiteab-science.com

Earnings

Reported EPS
Estimate

Next report: Mon, May 12, 2025

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Most widely held	0	0	—
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.